Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update Nov 6, 2024 08:00AM
Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update Oct 30, 2024 04:05PM
Aadi Bioscience (AADI) Provides PRECISION1 Trial and Corporate Updates Aug 20, 2024 05:00PM
Aadi Bioscience Provides PRECISION1 Trial and Corporate Updates Aug 20, 2024 05:00PM
Aadi Bioscience Announces Financial Results for the Second Quarter 2024 and Provides Corporate Update Aug 7, 2024 08:00AM
View Older Stories

Jul 31, 2024 04:05PM Aadi Bioscience to Report Second Quarter 2024 Results and Corporate Update
May 29, 2024 04:05PM Aadi Bioscience to Participate in the Jefferies Healthcare Conference
May 23, 2024 05:30PM Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting
May 8, 2024 08:00AM Aadi Bioscience Announces Financial Results for the First Quarter 2024 and Provides Corporate Update
May 1, 2024 08:01AM Aadi Bioscience to Report First Quarter 2024 Results and Corporate Update
Apr 9, 2024 08:21AM Aadi Bioscience (AADI) to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus
Apr 9, 2024 08:00AM Aadi Bioscience to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus at the American Association for Cancer Research (AACR) Annual Meeting
Mar 17, 2024 08:00AM Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)
Mar 13, 2024 08:00AM Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate Update
Mar 6, 2024 08:00AM Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate Update
Mar 5, 2024 04:30PM Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024
Mar 1, 2024 04:10PM Aadi Bioscience (AADI) Announces Publication of Long-Term Efficacy and Safety Data Supporting FYARRO
Mar 1, 2024 04:08PM Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComa
Feb 26, 2024 04:05PM Aadi Bioscience to Present at the TD Cowen 44th Annual Healthcare Conference
Jan 26, 2024 04:05PM Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium
Jan 19, 2024 04:05PM Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium
Dec 14, 2023 04:06PM Aadi Bioscience (AADI) Reports Interim Results from PRECISION1 Trial of nab-Sirolimus
Dec 14, 2023 04:05PM Aadi Bioscience Reports Interim Results from PRECISION1 Trial of nab-Sirolimus Demonstrating Anti-Tumor Activity in Solid Tumors with TSC1 or TSC2 Inactivating Alterations
Nov 8, 2023 08:00AM Aadi Bioscience Reports Financial Results for the Third Quarter 2023 and Provides Corporate Update
Nov 6, 2023 04:05PM Aadi Bioscience to Participate in Jefferies London Healthcare Conference
Nov 1, 2023 04:05PM Aadi Bioscience to Report Third Quarter 2023 Results and Operational Update
Oct 19, 2023 04:05PM Aadi Bioscience Announces Poster Presentations on Nab-Sirolimus at the International Gynecologic Cancer Society (IGCS) 2023 Annual Global Meeting
Oct 12, 2023 04:05PM Aadi Bioscience Announces Poster Presentations at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Oct 5, 2023 04:05PM Aadi Bioscience Announces Poster Presentations at the North American Neuroendocrine Tumor Society (NANETS) 2023 Multidisciplinary NET Medical Symposium
Oct 3, 2023 04:05PM Aadi Bioscience Grants New CEO Dave Lennon, Ph.D. Inducement Award Under Nasdaq Listing Rule 5635 (c)(4)
Oct 2, 2023 08:06AM Aadi Bioscience (AADI) Appoints Dave Lennon, Ph.D. as President and Chief Executive Officer
Oct 2, 2023 08:00AM Aadi Bioscience Appoints Dave Lennon, Ph.D. as President and Chief Executive Officer
Sep 20, 2023 04:30PM Aadi Bioscience Announces Poster Presentations at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Sep 5, 2023 08:00AM Aadi Bioscience to Participate at Upcoming Investor Conferences
Aug 9, 2023 08:00AM Aadi Bioscience Announces Financial Results for the Second Quarter 2023 and Provides Corporate Update
Aug 2, 2023 08:00AM Aadi Bioscience to Report Second Quarter 2023 Results and Operational Update
May 25, 2023 05:30PM Aadi Bioscience Announces Presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2023 08:00AM Aadi Bioscience to Participate in Upcoming Investor Events
May 10, 2023 08:04AM Aadi Bioscience (AADI) Reports Q1, Provides Update on PRECISION 1 Tumor Agnostic Trial
May 10, 2023 08:00AM Aadi Bioscience Announces Financial Results and Operational Update for the First Quarter 2023 and Provides Update on PRECISION 1 Tumor Agnostic Trial
Apr 26, 2023 04:05PM Aadi Bioscience Announces Multiple Presentations on nab-Sirolimus at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 14, 2023 01:09PM Aadi Bioscience to Present Multiple Posters on nab-Sirolimus at the 2023 American Association for Cancer Research (AACR) Annual Meeting
Apr 6, 2023 04:35PM Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2023
Mar 28, 2023 08:00AM Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2022 and Provides Corporate Update
Mar 27, 2023 08:01AM Aadi Bioscience (AADI) Appoints Mohammad Hirmand to its Board
Mar 27, 2023 08:00AM Aadi Bioscience Appoints Mohammad Hirmand, M.D. to Board of Directors
Mar 27, 2023 05:49AM Aadi Bioscience (AADI) Presents Clinical Data from PRECISION 1 and AMPECT Trials
Mar 26, 2023 02:00PM Aadi Bioscience Presents Clinical Data from PRECISION 1 and AMPECT Trials at the Society of Gynecological Oncology (SGO) Annual Meeting on Women's Cancer
Mar 15, 2023 08:00AM Aadi Bioscience to Report Fourth Quarter and Full-Year 2022 Results and Corporate Update
Mar 3, 2023 08:01AM Aadi Bioscience (AADI) Announces Leadership Transition
Mar 3, 2023 08:00AM Aadi Bioscience Announces Leadership Transition
Feb 22, 2023 08:00AM Aadi Bioscience to Present at the 43rd Annual Cowen Healthcare Conference
Nov 9, 2022 08:00AM Aadi Bioscience Announces Financial Results for the Third Quarter of 2022 and Provides Corporate Update
Nov 8, 2022 04:00PM Aadi Bioscience (AADI) Announces Management Changes
Nov 8, 2022 04:00PM Aadi Bioscience Announces Planned Leadership Transition
View Older Stories